Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

NCT03421236 is registered in ClinicalTrials.gov with Patrice Jichlinski as lead sponsor.

NCT NCT03421236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03421236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
Lead sponsor
Patrice Jichlinski
Phase
Phase 1
Overall status
Unknown status
Start date
February 18, 2018
Completion date
December 1, 2022
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non muscle invasive bladder cancer